Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Congress drug development Drug prices

	Profile	Recent Articles on Subject
1	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	ObesityWeek Roundup: Patients More Likely to Ration Obesity Drugs - 3 days ago Obesity Medication Type, Insurance Carrier Linked to Treatment Persistence - about 1 year ago Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Study - about 1 year ago
2	Jennifer Henderson MedPage Today Enterprise & Investigative Writer. Works with MedPage Today. Enterprise writinginvestigative journalismhealthcare	Obesity May Raise Risk of Long COVID in Youth - 17 days ago
3	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: A drug may cause problems with chemotherapies in cancer patients with obesity. Many doctors are in the dark - 17 days ago STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more - 4 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 9 months ago STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors - 11 months ago STAT+: Pharmalittle: Roche to buy obesity-drug developer for $2.7 billion; Novo Nordisk paid U.S. doctors $26 million over a decade - 12 months ago STAT+: Pharmalittle: Pfizer halts development of twice-daily obesity pill; Supreme Court to review Purdue bankruptcy deal - 12 months ago STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages - 12 months ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - about 1 year ago STAT+: Pharmalittle: People with obesity harmed by exclusion from studies; Teva sues Colorado over ‘unconstitutional’ program - about 1 year ago
4	Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom science	Daily briefing: What causes obesity? Contentious topic gets an authoritative analysis - 2 months ago
5	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	Report: A “Multifaceted Approach” Is Needed To Tackle the Obesity Epidemic - 3 months ago
6	Amanda Capritto CNET Non-Alcoholic Craft Beer. Low Cal, 0g Sugar. Pacific Northwest craft beernon-alcoholic beverages	Avoid These Weight Loss Habits To Keep Extra Pounds at Bay - 3 months ago
7	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Race for the Next Ozempic - 4 months ago
8	Kristen Monaco MedPage Today	Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 4 months ago Adolescent Obesity Tied to Parents' BMI at the Same Age - 5 months ago USPSTF Recommends Behavioral Interventions for Kids With High BMI - 5 months ago Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ - 7 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - 8 months ago Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes - 11 months ago Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry - 11 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 12 months ago Year in Review: Obesity - 12 months ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - 12 months ago Over One-Third of Adults in 22 States Have Obesity, CDC Says - about 1 year ago
9	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: A second Roche obesity drug shows promise in early studies - 4 months ago STAT+: Viking Therapeutics to move its oral obesity drug into Phase 2 study after early success - 8 months ago STAT+: Obesity treatment from Boehringer Ingelheim, Zealand Pharma succeeds in study in liver condition MASH - 9 months ago STAT+: What comes after Wegovy? The quest to eradicate obesity - 11 months ago STAT+: Pfizer to halt development of its twice-daily oral obesity drug, following disappointing trial - 12 months ago
10	The Conversation Science Alert Science news. Official account. Australia science news	Does Obesity Protect Against Dementia, or Increase Risk? - 7 months ago

Journalists covering obese